We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$257M
AUM Growth
-$13.3M
Cap. Flow
-$15.3M
Cap. Flow %
-5.95%
Top 10 Hldgs %
43.17%
Holding
259
New
67
Increased
65
Reduced
68
Closed
57

Top Buys

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$2.53M
2
MS icon
Morgan Stanley
MS
+$2.23M
3
CL icon
Colgate-Palmolive
CL
+$2.21M
4
TJX icon
TJX Companies
TJX
+$1.81M
5
SPYG icon
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
+$1.37M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.62M
2
MCD icon
McDonald's
MCD
+$2.54M
3
MDLZ icon
Mondelez International
MDLZ
+$2.52M
4
CI icon
Cigna
CI
+$2.32M
5
JPM icon
JPMorgan Chase
JPM
+$2.18M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 13.15%
3 Healthcare 9.82%
4 Consumer Discretionary 6.3%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VERX icon
251
Vertex
VERX
$1.98B
– –
-16,172
Closed -$514K
VTLE
252
DELISTED
Vital Energy
VTLE
– –
-10,211
Closed -$536K
VYGR icon
253
Voyager Therapeutics
VYGR
$197M
– –
-57,588
Closed -$536K
WDAY icon
254
Workday
WDAY
$44.8B
– –
-2,877
Closed -$785K
WDC icon
255
Western Digital
WDC
$151B
– –
-18,506
Closed -$955K
WSFS icon
256
WSFS Financial
WSFS
$4.14B
– –
-14,103
Closed -$637K
ZS icon
257
Zscaler
ZS
$28.9B
– –
-4,564
Closed -$879K
DCPH
258
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-33,297
Closed -$524K
PXD
259
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-1,148
Closed -$301K
7 8 9 10
11

Similar funds

CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
PC
Prysm Capital Princeton, New Jersey $10.6M AUM 2.38% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AVM
Altos Ventures Management Burlingame, California $11.7M AUM 182.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return

Alpha DNA Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Alpha DNA Investment Management held 259 positions worth $257M, down 4.9% from $271M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Alpha DNA Investment Management withdrew a net $15.3M in Q2 2024, closing 57 positions and reducing 68 holdings. Its most notable exit was Cigna, an estimated $2.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Alpha DNA Investment Management opened a new position in Colgate-Palmolive worth $2.32M.

  • Alpha DNA Investment Management's largest Q2 2024 buy was Colgate-Palmolive: 23,939 shares worth $2.32M.
  • Alpha DNA Investment Management added most to Wells Fargo in Q2 2024, an estimated $2.53M increase.
  • Alpha DNA Investment Management's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.62M.
  • Alpha DNA Investment Management fully exited Cigna in Q2 2024, selling an estimated $2.32M.
  • Alpha DNA Investment Management's ten largest holdings make up 43% of its $257M portfolio in Q2 2024.
  • Alpha DNA Investment Management opened 67 new positions and closed 57 in Q2 2024.
  • Alpha DNA Investment Management's portfolio value fell 4.9% quarter-over-quarter to $257M.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.